Latest Announcements

BSE & NSE corporate filings with AI summaries

BSEBoard MeetingFundraise9 Aug 2026

Natural Capsules Ltd

Natural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Update on board meeting 1. ....

Natural Capsules Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 12/08/2026 to consider and approve the unaudited consolidated & standalone financial results for the quarter ended June 30, 2026, and also to evaluate a proposal for raising funds by way of issue of equity shares, convertibles, and/or any other eligible securities on a preferential basis.

Read more →📎 1 attachment
BSEAGM/EGMFundraise9 Aug 2026

Cosmic CRF Ltd

An Extra Ordinary General Meeting ("EOGM") of Cosmic CRF Limited shall be held on Wednesday, September 2, 2026 at 3:00 P.M. (IST) via VC/OACM facility.

Cosmic CRF Ltd has called an Extra-Ordinary General Meeting (EOGM) to consider a special resolution for the further issue of up to 7,25,041 equity shares on a preferential basis for the acquisition of 30,71,025 (26%) fully paid-up equity shares of M/S. N. S. Engineering Projects Pvt. Ltd. through a share swap to make it a wholly owned subsidiary.

Read more →📎 1 attachment
BSEOthersFundraise8 Aug 2026

Unifinz Capital India Ltd

Prior intimation of Asset Liability Management Committee for fundraising through issue of Non-convertible debentures

Unifinz Capital India Ltd has informed the BSE that its Asset Liability Management Committee will meet on August 12, 2026, to consider and approve a proposal to raise funds by issuing non-convertible debentures (NCDs) up to Rs. 1000 crore. This is within the overall borrowing limit approved by the shareholders at the Annual General Meeting held on July 2, 2026.

Read more →📎 1 attachment
BSEBoard MeetingFundraise8 Aug 2026

Leo Dryfruits & Spices Trading Ltd

Pursuant to Regulation 30 read with Schedule III and other applicable provisions of SEBI (LODR) Regulations, 2015 the Board of Directors in its Meeting held on August 8, 2026 have approved:- 1. ....

Leo Dryfruits & Spices Trading Ltd has approved raising of funds by way of preferential issue of up to 70,00,000 Fully Convertible Warrants at an issue price of X55/- per Warrant, aggregating up to %38,50,00,000/-, and convening an Extraordinary General Meeting to seek approval for the aforesaid preferential issue.

Read more →📎 1 attachment
BSEBoard MeetingFundraise8 Aug 2026

Aptus Pharma Ltd

please find attached outcome of board meeting dated 08.08.2026 for approval of preferential issue of shares

Aptus Pharma Ltd has announced the outcome of its board meeting, where it approved the preferential issue of 16,10,100 equity shares at a price to be determined by a registered valuer. The company also fixed the date of its annual general meeting for September 14, 2026. The preferential issue is subject to the approval of the shareholders and other necessary approvals.

Read more →📎 1 attachment
BSECompany UpdateFundraise8 Aug 2026

Veefin Solutions Ltd

The Board of Directors of the company has approved for the allotment of 3,00,000 unrated, unlisted, secured, redeemable non-convertible debentures having a face value of INR 1,000/- (One ....

Veefin Solutions Ltd has announced the allotment of 3,00,000 unrated, unlisted, secured, redeemable non-convertible debentures with a face value of INR 1,000 each, aggregating to INR 30,00,00,000, to Stride Ventures Debt Fund 4 on a private placement basis.

Read more →📎 1 attachment
BSECompany UpdateFundraise8 Aug 2026

Medi Assist Healthcare Services Ltd

As enclosed

Medi Assist Healthcare Services Ltd has filed a statement of deviation or variation in the utilization of funds raised through a Preferential Issue for the quarter ended June 30, 2026, stating that there has been no deviation or variation in the use of funds raised. The company has also enclosed a Monitoring Agency Report issued by CARE Ratings Limited.

Read more →📎 1 attachment
BSECompany UpdateFundraise8 Aug 2026

Medi Assist Healthcare Services Ltd

As enclosed

Medi Assist Healthcare Services Ltd has filed a statement of deviation or variation in the utilization of funds raised through a preferential issue for the quarter ended June 30, 2026, stating that there has been no deviation or variation in the use of funds raised. The company has also enclosed a monitoring agency report issued by CARE Ratings Limited.

Read more →📎 1 attachment
BSECompany UpdateFundraise8 Aug 2026

Chemkart India Ltd

Disclosure under Regulation 30 of SEBI LOD Regulations 2015 for Acqusition of Equity Shares in Wholly-Owned Subsidiary Company.

Chemkart India Ltd has made an investment of Rs. 1.00 Crores by issuing and allotting 10,00,000 Equity Shares of face value of Rs. 10/- each at an issue price of Rs. 10/- each in Easy Raw Materials Private Limited, a Wholly Owned Subsidiary, through a Rights Issue. The acquisition is a part of the utilization of the proceeds as specified in the Prospectus dated 10th July 2025.

Read more →📎 1 attachment
BSECompany UpdateFundraise7 Aug 2026

Kesar India Ltd

Statement of Deviation and Variation

Kesar India Ltd has submitted a statement to BSE regarding the utilization of proceeds from its preferential issue, stating that there are no deviations or variations in the utilization of the proceeds during the quarter ended June 30, 2026.

Read more →📎 1 attachment
BSECompany UpdateFundraise7 Aug 2026

Deccan Gold Mines Ltd

Preferential Issue of Securities

Deccan Gold Mines Ltd has announced a preferential issue of securities, including Compulsorily Convertible Debentures (CCDs), Equity Shares, and Equity Warrants, to non-promoter entities, aggregating up to Rs. 1,84,65,46,463. The issue price is Rs. 191.90 per unit, and the securities are convertible into equity shares within 18 months, subject to shareholder and regulatory approvals.

Read more →📎 1 attachment
BSECompany UpdateFundraise7 Aug 2026

Zodiac-JRD-MKJ Ltd

Refer attached document

Zodiac-JRD-MKJ Ltd has proposed a rights issue of up to ₹40,00,00,000 to eligible equity shareholders, with a face value of ₹10 each, at an issue price of ₹ [•] per equity share.

Read more →📎 1 attachment